Why a Fund Made a $143 Million Bet on Indivior With Shares Up a Staggering 200%
2026-05-30 15:17:39 ET
On May 15, 2026, Madison Avenue Partners disclosed a new position in Indivior (NASDAQ:INDV) , acquiring 4,315,162 shares in the first quarter—an estimated $142.51 million trade based on quarterly average pricing.
According to its SEC filing dated May 15, 2026, Madison Avenue Partners opened a new position in Indivior (NASDAQ:INDV) during the first quarter by acquiring 4,315,162 shares. The estimated value of the trade was $142.51 million, calculated using the mean unadjusted closing price over the quarter. At quarter’s end, the stake was valued at $131.53 million, reflecting both trading activity and price movements.
Indivior is a specialty pharmaceutical company focused on addressing opioid dependence through proprietary buprenorphine-based therapies. The company leverages its expertise in addiction treatment and operates in the United States, Rest of World, and United Kingdom markets.
NASDAQ: INDV
INDV Trading
1.7% G/L:
$38.35 Last:
353,549 Volume:
$37.58 Open:
